Retinopatia diabética

Nehemy, Márcio B.

doi:10.5935/0004-2749.19980067

Texto completo disponível apenas em PDF.

REFERENCIAS BIBLIOGRAFICAS

¹
Klein R, Klein Bek, Moss SE, Davis MD, Demets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy 11. Prevalence and Risk of Oabetic Retinopathy when age at Diagnosis is less than 30 years. Arch Ophthalmol 1984;I 02:520-6.
²
Mcmeel JW, Jalkh AE. Vitreous changes in vascular diseases. In: Schepens CL, Neetens A (ed.). The vitreous and vitreoretinal Interface, Springer-Verlag, New York 1987;9:133-53.
³
Feldman JN, Hirsch SR, Beyer MM et al. Prevalence of diabetic nephropathy at any time of treatment for diabetic retinopathy. In Friedman EA, L'Esperance FA (eds.): Diabetic Renal-Retina) Syndrome, vol. 2, p.9. New York, Grune & Stratton, 1982.
⁴
Janka HV, Warram JH, Rand LI et al. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 1989;38:460-7.
⁵
Klein R, Klein Bek, Moss SE. The epidemiology of proliferative diabetic retinopathy - Diabetes Care 1992;15:1875-91.
⁶
Chew EY, Klein ML, Ferris, FL, Remaley NA. The Early Treatment Diabetic Retinopathy Study research group. Association of elevated serum lipids with retina) hard exsudate in diabetic retinopathy. ETDRS report # 22. Arch Ophthalmol 1996;114:1079-84.
⁷
Early Treatment Diabetic, Retinopathy Study Research Group: Effects Of Aspirin Treatment On Diabetic Retinopathy. ETDRS report # 8. Ophthalmology 1991;98:757-65.
⁸
Ohrt V. The influence of pregnancy on diabetic retinopathy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol 1984;62:603-1 O.
⁹
Bresnick GL, Korth K, Groo A et al. Eletroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 1984;102:1307-15.
¹⁰
Beetham WP. Visual Prognosis of proliferating diabetic retinopathy. Br J Ophthalmol 1963;47:611-9.
¹¹
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical aplication of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 1981;88:583-600.
¹²
The Diabetic Control and Complication Trial Research Group. The effect of intensive diabetes treatment and the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995;113:36-51.
¹³
Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema: Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985;I 03:1796-806.
¹⁴
Ho T, Smiddy WE, Flynn HW. Vitrectomy in the management of Diabetic Eye Disease. Surv Ophthalmol 1992;37: 190-202.
¹⁵
Duke-Elder S. System of Ophthalmology, Vol. 10. St. Louis, CV Mosby, p.410, 1967.

Datas de Publicação

Publicação nesta coleção
Jun 1998

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.

[1] ¹
Klein R, Klein Bek, Moss SE, Davis MD, Demets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy 11. Prevalence and Risk of Oabetic Retinopathy when age at Diagnosis is less than 30 years. Arch Ophthalmol 1984;I 02:520-6.

[2] ²
Mcmeel JW, Jalkh AE. Vitreous changes in vascular diseases. In: Schepens CL, Neetens A (ed.). The vitreous and vitreoretinal Interface, Springer-Verlag, New York 1987;9:133-53.

[3] ³
Feldman JN, Hirsch SR, Beyer MM et al. Prevalence of diabetic nephropathy at any time of treatment for diabetic retinopathy. In Friedman EA, L'Esperance FA (eds.): Diabetic Renal-Retina) Syndrome, vol. 2, p.9. New York, Grune & Stratton, 1982.

[4] ⁴
Janka HV, Warram JH, Rand LI et al. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 1989;38:460-7.

[5] ⁵
Klein R, Klein Bek, Moss SE. The epidemiology of proliferative diabetic retinopathy - Diabetes Care 1992;15:1875-91.

[6] ⁶
Chew EY, Klein ML, Ferris, FL, Remaley NA. The Early Treatment Diabetic Retinopathy Study research group. Association of elevated serum lipids with retina) hard exsudate in diabetic retinopathy. ETDRS report # 22. Arch Ophthalmol 1996;114:1079-84.

[7] ⁷
Early Treatment Diabetic, Retinopathy Study Research Group: Effects Of Aspirin Treatment On Diabetic Retinopathy. ETDRS report # 8. Ophthalmology 1991;98:757-65.

[8] ⁸
Ohrt V. The influence of pregnancy on diabetic retinopathy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol 1984;62:603-1 O.

[9] ⁹
Bresnick GL, Korth K, Groo A et al. Eletroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 1984;102:1307-15.

[10] ¹⁰
Beetham WP. Visual Prognosis of proliferating diabetic retinopathy. Br J Ophthalmol 1963;47:611-9.

[11] ¹¹
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical aplication of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 1981;88:583-600.

[12] ¹²
The Diabetic Control and Complication Trial Research Group. The effect of intensive diabetes treatment and the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995;113:36-51.

[13] ¹³
Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema: Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985;I 03:1796-806.

[14] ¹⁴
Ho T, Smiddy WE, Flynn HW. Vitrectomy in the management of Diabetic Eye Disease. Surv Ophthalmol 1992;37: 190-202.

[15] ¹⁵
Duke-Elder S. System of Ophthalmology, Vol. 10. St. Louis, CV Mosby, p.410, 1967.

Brasil

Brasil

Retinopatia diabética

Diabetic retinopathy

REFERENCIAS BIBLIOGRAFICAS

Datas de Publicação